Form 4: Intuitive Surgical CFO Jamie Samath Executes Stock Option Trades Under 10b5-1 Plan

Intuitive Surgical's CFO, Jamie Samath, executed stock option exercises and sales on November 26, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Jamie Samath, CFO of Intuitive Surgical, engaged in multiple transactions involving the company's common stock on November 26, 2024.
• These transactions included the exercise of non-qualified stock options and the subsequent sale of the acquired shares.
• The transactions were executed under a pre-arranged trading plan that complies with SEC Rule 10b5-1.
• A total of 108 shares were acquired through option exercises at prices of $245.6 and $347.4167 per share.
• The same 108 shares were then sold at a price of $542.06 per share.
• Following these transactions, Mr. Samath directly owns 8,757 shares of Intuitive Surgical common stock and 159 non-qualified stock options at each of the two exercise prices.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing for insider transactions, which is neither positive nor negative. It reflects standard executive compensation practices.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, which is a common practice for corporate insiders to avoid accusations of insider trading.
• The CFO exercised options at lower prices and sold the shares at a higher price, indicating a potential profit.

Risks

• While the transactions are under a 10b5-1 plan, any large volume of insider sales can sometimes be perceived negatively by the market.

Industry Context

This is a routine filing for insider transactions and is common for executives of publicly traded companies. The use of a 10b5-1 plan is a standard practice to manage insider trading risks.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the medical device industry such as Medtronic (MDT) and Stryker (SYK).
• These plans allow insiders to sell shares without being accused of trading on non-public information.
• The vesting schedules of the options are also typical for executive compensation packages in the tech and medical device sectors.

Stakeholder Impact

• The transactions have a minimal impact on stakeholders as they are part of a pre-arranged trading plan and do not indicate any change in the company's fundamentals.

Key Dates

Keywords

Intuitive Surgical, ISRG, Jamie Samath, Stock Options, SEC Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, CFO